Circadian clocks, epigenetics, and cancer : Current Opinion in Oncology

Secondary Logo

Journal Logo

CANCER BIOLOGY: Edited by Pierre Hainaut and Amelie Plymoth

Circadian clocks, epigenetics, and cancer

Masri, Selma; Kinouchi, Kenichiro; Sassone-Corsi, Paolo

Author Information
Current Opinion in Oncology 27(1):p 50-56, January 2015. | DOI: 10.1097/CCO.0000000000000153

Abstract

Purpose of review 

The interplay between circadian rhythm and cancer has been suggested for more than a decade based on the observations that shift work and cancer incidence are linked. Accumulating evidence implicates the circadian clock in cancer survival and proliferation pathways. At the molecular level, multiple control mechanisms have been proposed to link circadian transcription and cell-cycle control to tumorigenesis.

Recent findings 

The circadian gating of the cell cycle and subsequent control of cell proliferation is an area of active investigation. Moreover, the circadian clock is a transcriptional system that is intricately regulated at the epigenetic level. Interestingly, the epigenetic landscape at the level of histone modifications, DNA methylation, and small regulatory RNAs are differentially controlled in cancer cells. This concept raises the possibility that epigenetic control is a common thread linking the clock with cancer, though little scientific evidence is known to date.

Summary 

This review focuses on the link between circadian clock and cancer, and speculates on the possible connections at the epigenetic level that could further link the circadian clock to tumor initiation or progression.

© 2015 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid